Therapeutic aspects of Sydenham's Chorea: an update

Therapeutic aspects of Sydenham's Chorea: an update

Authors

  • Greta Depietri Pediatric Neurology, Pediatric University Department, Azienda Ospedaliera Universitaria Pisana, University of Pisa
  • Niccolo Carli Pediatric Neurology, Pediatric University Department, Azienda Ospedaliera Universitaria Pisana, University of Pisa
  • Attilio Sica Pediatric Neurology, Pediatric University Department, Azienda Ospedaliera Universitaria Pisana, University of Pisa
  • Domenico Oliviero Pediatric Neurology, Pediatric University Department, Azienda Ospedaliera Universitaria Pisana, University of Pisa
  • Giorgio Costagliola Pediatric Neurology, Pediatric University Department, Azienda Ospedaliera Universitaria Pisana, University of Pisa, Pisa, Italy
  • Pasquale Striano Pediatric Neurology Unit, Dinogmi, Giannina Gaslini’s. Istitute, University of Genoa, Italy
  • Alice Bonuccelli Pediatric Neurology, Pediatric University Department, Azienda Ospedaliera Universitaria Pisana, University of Pisa, Italy
  • Flavia Frisone Pediatric Neurology, Pediatric University Department, Azienda Ospedaliera Universitaria Pisana, University of Pisa, Italy
  • Diego Peroni Pediatric Neurology, Pediatric University Department, Azienda Ospedaliera Universitaria Pisana, University of Pisa, Italy
  • Rita Consolini Pediatric Neurology, Pediatric University Department, Azienda Ospedaliera Universitaria Pisana, University of Pisa, Italy
  • Thomas Foiadelli Pediatric Clinic, IRCCS Policlinico San Matteo Foundation, University of Pavia, Pavia
  • Alessandro Orsini Pediatric Neurology, Pediatric University Department, Azienda Ospedaliera Universitaria Pisana, University of Pisa, Italy

Keywords:

Acute Rheumatic Fever, Beta-Hemolytic Streptococcal Pharyngitis, Hyperkinetic Movement Disorder, Sydenham’s Chorea

Abstract

Sydenham’s Chorea (SC) is a hyperkinetic movement disorder associated with neuropsychiatric manifestations. It is believed to be caused by the autoimmune response following a group A beta-hemolytic streptococcal (GABHS) pharyngitis, and it is one of the major diagnostic criteria for Acute Rheumatic Fever (ARF) diagnosis.

Despite having been known and studied for centuries, there are still no standardized therapies or official guidelines for SC treatment, so that it is necessarily left to physicians’ clinical experience. Antibiotic treatment, symptomatic therapies, and immunomodulatory treatment are the three pillars upon which SC patients’ management is currently based, but they still lack a solid scientific basis.

The aim of this writing is precisely to review the state of the art of SC’s treatment, with an overview of the advances made in the last 5 years. However, since the therapeutic uncertainties are a mere reflection of the severe gap of knowledge that concerns SC’s pathogenesis and manifestations, the importance of high-quality research studies based on homogenized methodologies, instruments, and measured outcomes will also be stressed.

References

Marques-Dias MJ, Mercadante MT, Tucker D, Lombroso P. Sydenham's chorea. Psychiatr Clin North Am. 1997;20(4):809-20.

Cardoso F. Sydenham's Chorea. Curr Treat Options Neurol. 2008;10(3):230-5.

Punukollu M, Mushet N, Linney M, Hennessy C, Morton M. Neuropsychiatric manifestations of Sydenham's chorea: a systematic review. Dev Med Child Neurol. 2016;58(1):16-28.

Eshel G, Lahat E, Azizi E, Gross B, Aladjem M. Chorea as a manifestation of rheumatic fever--a 30-year survey (1960-1990). Eur J Pediatr. 1993;152(8):645-6.

Baizabal-Carvallo JF, Jankovic J. Movement disorders in autoimmune diseases. Mov Disord. 2012;27(8):935-46.

Cardoso F, Vargas AP, Oliveira LD, Guerra AA, Amaral SV. Persistent Sydenham's chorea. Mov Disord. 1999;14(5):805-7.

Korn-Lubetzki I, Brand A, Steiner I. Recurrence of Sydenham chorea: implications for pathogenesis. Arch Neurol. 2004;61(8):1261-4.

Gewitz MH, Baltimore RS, Tani LY, Sable CA, Shulman ST, Carapetis J, et al. Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association. Circulation. 2015;131(20):1806-18.

Kirvan CA, Swedo SE, Heuser JS, Cunningham MW. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med. 2003;9(7):914-20.

Seckeler MD, Hoke TR. The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease. Clin Epidemiol. 2011;3:67-84.

Cunningham MW, Cox CJ. Autoimmunity against dopamine receptors in neuropsychiatric and movement disorders: a review of Sydenham chorea and beyond. Acta Physiol (Oxf). 2016;216(1):90-100.

Cardoso F, Eduardo C, Silva AP, Mota CC. Chorea in fifty consecutive patients with rheumatic fever. Mov Disord. 1997;12(5):701-3.

Tumas V, Caldas CT, Santos AC, Nobre A, Fernandes RM. Sydenham's chorea: clinical observations from a Brazilian movement disorder clinic. Parkinsonism Relat Disord. 2007;13(5):276-83.

MATTHEWS R, WILLIAMS H, RICKARDS W, WATERHOUSE I, ALLAN J. Sydenham's chorea: its relationship to rheumatic infection and psychological illness. Med J Aust. 1960;47(2):771-4.

Giotta Lucifero A, Luzzi S, Brambilla I, Trabatti C, Mosconi M, Savasta S, et al. Innovative therapies for malignant brain tumors: the road to a tailored cure. Acta Biomed. 2020;91(7-s):5-17.

Luzzi S, Crovace AM, Del Maestro M, Giotta Lucifero A, Elbabaa SK, Cinque B, et al. The cell-based approach in neurosurgery: ongoing trends and future perspectives. Heliyon. 2019;5(11):e02818.

Luzzi S, Crovace AM, Lacitignola L, Valentini V, Francioso E, Rossi G, et al. Engraftment, neuroglial transdifferentiation and behavioral recovery after complete spinal cord transection in rats. Surg Neurol Int. 2018;9:19.

Bellantoni G, Guerrini F, Del Maestro M, Galzio R, Luzzi S. Simple schwannomatosis or an incomplete Coffin-Siris? Report of a particular case. eNeurologicalSci. 2019;14:31-3.

Luzzi S, Giotta Lucifero A, Brambilla I, Magistrali M, Mosconi M, Savasta S, et al. Adoptive immunotherapies in neuro-oncology: classification, recent advances, and translational challenges. Acta Biomed. 2020;91(7-s):18-31.

Luzzi S, Giotta Lucifero A, Brambilla I, Trabatti C, Mosconi M, Savasta S, et al. The impact of stem cells in neuro-oncology: applications, evidence, limitations and challenges. Acta Biomed. 2020;91(7-s):51-60.

Giotta Lucifero A, Luzzi S, Brambilla I, Guarracino C, Mosconi M, Foiadelli T, et al. Gene therapies for high-grade gliomas: from the bench to the bedside. Acta Biomed. 2020;91(7-s):32-50.

Karthikeyan G, Guilherme L. Acute rheumatic fever. Lancet. 2018;392(10142):161-74.

Foiadelli T, Naso M, Licari A, Orsini A, Magistrali M, Trabatti C, et al. Advanced pharmacological therapies for neurofibromatosis type 1-related tumors. Acta Biomed. 2020;91(7-s):101-14.

Giotta Lucifero A, Luzzi S, Brambilla I, Schena L, Mosconi M, Foiadelli T, et al. Potential roads for reaching the summit: an overview on target therapies for high-grade gliomas. Acta Biomed. 2020;91(7-s):61-78.

Luzzi S, Giotta Lucifero A, Brambilla I, Semeria Mantelli S, Mosconi M, Foiadelli T, et al. Targeting the medulloblastoma: a molecular-based approach. Acta Biomed. 2020;91(7-s):79-100.

Giotta Lucifero A, Luzzi S. Against the Resilience of High-Grade Gliomas: The Immunotherapeutic Approach (Part I). Brain Sci. 2021;11(3).

Savioli G, Ceresa IF, Macedonio S, Gerosa S, Belliato M, Iotti GA, et al. Trauma Coagulopathy and Its Outcomes. Medicina (Kaunas). 2020;56(4).

Walker K, Brink A, Lawrenson J, Mathiassen W, Wilmshurst JM. Treatment of sydenham chorea with intravenous immunoglobulin. J Child Neurol. 2012;27(2):147-55.

Miranda M, Walker RH, Saez D, Renner V. Severe Sydenham's chorea (chorea paralytica) successfully treated with plasmapheresis. J Clin Mov Disord. 22015. p. 2.

Orsini A, Foiadelli T, Magistrali M, Carli N, Bagnasco I, Dassi P, et al. A nationwide study on Sydenham's chorea: Clinical features, treatment and prognostic factors. Eur J Paediatr Neurol. 2021;36:1-6.

Teixeira AL, Vasconcelos LP, Nunes M, Singer H. Sydenham's chorea: from pathophysiology to therapeutics. Expert Rev Neurother. 2021;21(8):913-22.

Yilmaz S, Mink JW. Treatment of Chorea in Childhood. Pediatr Neurol. 2020;102:10-9.

Risavi BL, Iszkula E, Yost B. Sydenham's Chorea. J Emerg Med. 2019;56(6):e119-e21.

Shields WD, Bray PF. A danger of haloperidol therapy in children. J Pediatr. 1976;88(2):301-3.

Shannon KM, Fenichel GM. Pimozide treatment of Sydenham's chorea. Neurology. 1990;40(1):186.

al-Eissa A. Sydenham's chorea: a new look at an old disease. Br J Clin Pract. 1993;47(1):14-6.

Axley J. Rheumatic chorea controlled with haloperidol. J Pediatr. 1972;81(6):1216-7.

Oosterveer DM, Overweg-Plandsoen WC, Roos RA. Sydenham's chorea: a practical overview of the current literature. Pediatr Neurol. 2010;43(1):1-6.

Harel L, Zecharia A, Straussberg R, Volovitz B, Amir J. Successful treatment of rheumatic chorea with carbamazepine. Pediatr Neurol. 2000;23(2):147-51.

Alvarez LA, Novak G. Valproic acid in the treatment of Sydenham chorea. Pediatr Neurol. 1985;1(5):317-9.

Cardoso F, Maia D, Cunningham MC, Valença G. Treatment of Sydenham chorea with corticosteroids. Mov Disord. 2003;18(11):1374-7.

Walker AR, Tani LY, Thompson JA, Firth SD, Veasy LG, Bale JF, Jr. Rheumatic chorea: relationship to systemic manifestations and response to corticosteroids. J Pediatr. 2007;151(6):679-83.

Dean SL, Singer HS. Treatment of Sydenham's Chorea: A Review of the Current Evidence. Tremor Other Hyperkinet Mov (N Y). 2017;7:456.

Fusco C, Spagnoli C. Corticosteroid treatment in Sydenham's chorea. Eur J Paediatr Neurol. 2018;22(2):327-31.

Fusco C, Ucchino V, Frattini D, Pisani F, Della Giustina E. Acute and chronic corticosteroid treatment of ten patients with paralytic form of Sydenham's chorea. Eur J Paediatr Neurol. 2012;16(4):373-8.

Paz JA, Silva CA, Marques-Dias MJ. Randomized double-blind study with prednisone in Sydenham's chorea. Pediatr Neurol. 2006;34(4):264-9.

Faustino PC, Terreri MT, da Rocha AJ, Zappitelli MC, Lederman HM, Hilário MO. Clinical, laboratory, psychiatric and magnetic resonance findings in patients with Sydenham chorea. Neuroradiology. 2003;45(7):456-62.

Green LN. Corticosteroids in the treatment of Sydenham's chorea. Arch Neurol. 1978;35(1):53-4.

Barash J, Margalith D, Matitiau A. Corticosteroid treatment in patients with Sydenham's chorea. Pediatr Neurol. 2005;32(3):205-7.

Daoud AS, Zaki M, Shakir R, al-Saleh Q. Effectiveness of sodium valproate in the treatment of Sydenham's chorea. Neurology. 1990;40(7):1140-1.

Araujo AP, Padua PA, Maia Filho HS. Management of rheumatic chorea: an observational study. Arq Neuropsiquiatr. 2002;60(2-a):231-3.

Garvey MA, Snider LA, Leitman SF, Werden R, Swedo SE. Treatment of Sydenham's chorea with intravenous immunoglobulin, plasma exchange, or prednisone. J Child Neurol. 2005;20(5):424-9.

Teixeira AL, Jr., Maia DP, Cardoso F. Treatment of acute Sydenham's chorea with methyl-prednisolone pulse-therapy. Parkinsonism Relat Disord. 2005;11(5):327-30.

Ali A, Anugwom GO, Rehman U, Khalid MZ, Saeeduddin MO. Sydenham Chorea Managed With Immunoglobulin in Acute Rheumatic Fever. Cureus. 2021;13(5):e14990.

Gadian J, Kirk E, Holliday K, Lim M, Absoud M. Systematic review of immunoglobulin use in paediatric neurological and neurodevelopmental disorders. Dev Med Child Neurol. 2017;59(2):136-44.

Zykov VP, Shcherbina AY, Novikova EB, Shvabrina TV. Neuroimmune aspects of the pathogenesis of Tourette's syndrome and experience in the use of immunoglobulins in children. Neurosci Behav Physiol. 2009;39(7):635-8.

van Immerzeel TD, van Gilst RM, Hartwig NG. Beneficial use of immunoglobulins in the treatment of Sydenham chorea. Eur J Pediatr. 2010;169(9):1151-4.

Boersma NA, Schippers H, Kuijpers T, Heidema J. Successful treatment of Sydenham's chorea with intravenous immunoglobulin. BMJ Case Rep. 2016;2016.

Mohammad SS, Nosadini M, Grattan-Smith P, Dale RC. Intravenous immunoglobulin in acute Sydenham's chorea: A systematic review. J Paediatr Child Health. 2015;51(12):1235-8.

Gregorowski C, Lochner C, Martin L, Simmons C, Kidd M, Walker K, et al. Neuropsychological manifestations in children with Sydenham's chorea after adjunct intravenous immunoglobulin and standard treatment. Metab Brain Dis. 2016;31(1):205-12.

Church AJ, Cardoso F, Dale RC, Lees AJ, Thompson EJ, Giovannoni G. Anti-basal ganglia antibodies in acute and persistent Sydenham's chorea. Neurology. 2002;59(2):227-31.

Cortese I, Chaudhry V, So YT, Cantor F, Cornblath DR, Rae-Grant A. Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2011;76(3):294-300.

Teixeira AL, Barbosa IG, Diniz BS, Kummer A. Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function. Biomark Med. 2010;4(6):871-87.

Moreira J, Kummer A, Harsányi E, Cardoso F, Teixeira AL. Psychiatric disorders in persistent and remitted Sydenham's chorea. Parkinsonism Relat Disord. 2014;20(2):233-6.

Emery ES, Vieco PT. Sydenham Chorea: magnetic resonance imaging reveals permanent basal ganglia injury. Neurology. 1997;48(2):531-3.

Beato R, Maia DP, Teixeira AL, Cardoso F. Executive functioning in adult patients with Sydenham's chorea. Mov Disord. 2010;25(7):853-7.

Harrison NA, Church A, Nisbet A, Rudge P, Giovannoni G. Late recurrences of Sydenham's chorea are not associated with anti-basal ganglia antibodies. J Neurol Neurosurg Psychiatry. 2004;75(10):1478-9.

Bhidayasiri R, Truong DD. Chorea and related disorders. Postgrad Med J. 2004;80(947):527-34.

Nosadini M, Granata T, Matricardi S, Freri E, Ragona F, Papetti L, et al. Relapse risk factors in anti-N-methyl-D-aspartate receptor encephalitis. Dev Med Child Neurol. 2019;61(9):1101-7.

Majeed HA, Shaltout A, Yousof AM. Recurrences of acute rheumatic fever. A prospective study of 79 episodes. Am J Dis Child. 1984;138(4):341-5.

FEINSTEIN AR, SPAGNUOLO M. Mimetic features of rheumatic-fever recurrences. N Engl J Med. 1960;262:533-40.

Feinstein AR, Stern EK. Clinical effects of recurrent attacks of acute rheumatic fever: a prospective epidemiologic study of 105 episodes. J Chronic Dis. 1967;20(1):13-27.

Downloads

Published

21-03-2022

How to Cite

1.
Therapeutic aspects of Sydenham’s Chorea: an update . Acta Biomed [Internet]. 2022 Mar. 21 [cited 2024 May 27];92(S4):e2021414. Available from: https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/12663

Most read articles by the same author(s)

1 2 > >>